Identification and Mendelian randomization validation of pathogenic gene biomarkers in obstructive sleep apnea

BackgroundBy 2020, obstructive sleep apnea (OSA), a prevalent respiratory disorder, had affected 26.6–43.2% of males and 8.7–27.8% of females worldwide. OSA is associated with conditions such as hypertension, diabetes, and tumor progression; however, the precise underlying pathways remain elusive. T...

Full description

Bibliographic Details
Published in:Frontiers in Neurology
Main Authors: Nianjin Gong, Yu Tuo, Peijun Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-08-01
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2024.1442835/full
_version_ 1850368654163574784
author Nianjin Gong
Yu Tuo
Peijun Liu
author_facet Nianjin Gong
Yu Tuo
Peijun Liu
author_sort Nianjin Gong
collection DOAJ
container_title Frontiers in Neurology
description BackgroundBy 2020, obstructive sleep apnea (OSA), a prevalent respiratory disorder, had affected 26.6–43.2% of males and 8.7–27.8% of females worldwide. OSA is associated with conditions such as hypertension, diabetes, and tumor progression; however, the precise underlying pathways remain elusive. This study aims to identify genetic markers and molecular mechanisms of OSA to improve understanding and treatment strategies.MethodsThe GSE135917 dataset related to OSA was obtained from the GEO database. Differentially expressed genes (DEGs) were subsequently identified. Weighted gene co-expression network analysis (WGCNA) was conducted to pinpoint disease-associated genes. The intersection of these data enabled the identification of potential diagnostic DEGs. Further analyses included Gene Ontology and Kyoto Encyclopedia of Genes and Genomes enrichment studies, exploration of protein–protein interactions based on these genes, and an examination of immune infiltration. Mendelian randomization was employed to validate core genes against the Genome-Wide Association Study database.ResultsA total of 194 DEGs were identified in this study. WGCNA network analysis highlighted 2,502 DEGs associated with OSA. By intersecting these datasets, 53 diagnostic DEGs primarily involved in metabolic pathways were identified. Significant alterations were observed in immune cell populations, including memory B cells, plasma cells, naive CD4 T cells, M0 macrophages, and activated dendritic cells. CETN3, EEF1E1, PMM2, GTF2A2, and RRM2 emerged as hub genes implicated in the pathogenesis. A line graph model provides diagnostic insights. Mendelian randomization analysis confirmed a causal link between CETN3 and GTF2A2 with OSA.ConclusionThrough WGCNA, this analysis uncovered significant genetic foundations of OSA, identifying 2,502 DEGs and 194 genes associated with the disorder. Among these, CETN3 and GTF2A2 were found to have causal relationships with OSA.
format Article
id doaj-art-6902a36252be4bc5a1fa341fbf5ede4e
institution Directory of Open Access Journals
issn 1664-2295
language English
publishDate 2024-08-01
publisher Frontiers Media S.A.
record_format Article
spelling doaj-art-6902a36252be4bc5a1fa341fbf5ede4e2025-08-19T23:02:25ZengFrontiers Media S.A.Frontiers in Neurology1664-22952024-08-011510.3389/fneur.2024.14428351442835Identification and Mendelian randomization validation of pathogenic gene biomarkers in obstructive sleep apneaNianjin Gong0Yu Tuo1Peijun Liu2Department of Respiratory and Critical Care Medicine, The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, Enshi, ChinaDepartment of Oncology, The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, Enshi, ChinaDepartment of Respiratory and Critical Care Medicine, The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, Enshi, ChinaBackgroundBy 2020, obstructive sleep apnea (OSA), a prevalent respiratory disorder, had affected 26.6–43.2% of males and 8.7–27.8% of females worldwide. OSA is associated with conditions such as hypertension, diabetes, and tumor progression; however, the precise underlying pathways remain elusive. This study aims to identify genetic markers and molecular mechanisms of OSA to improve understanding and treatment strategies.MethodsThe GSE135917 dataset related to OSA was obtained from the GEO database. Differentially expressed genes (DEGs) were subsequently identified. Weighted gene co-expression network analysis (WGCNA) was conducted to pinpoint disease-associated genes. The intersection of these data enabled the identification of potential diagnostic DEGs. Further analyses included Gene Ontology and Kyoto Encyclopedia of Genes and Genomes enrichment studies, exploration of protein–protein interactions based on these genes, and an examination of immune infiltration. Mendelian randomization was employed to validate core genes against the Genome-Wide Association Study database.ResultsA total of 194 DEGs were identified in this study. WGCNA network analysis highlighted 2,502 DEGs associated with OSA. By intersecting these datasets, 53 diagnostic DEGs primarily involved in metabolic pathways were identified. Significant alterations were observed in immune cell populations, including memory B cells, plasma cells, naive CD4 T cells, M0 macrophages, and activated dendritic cells. CETN3, EEF1E1, PMM2, GTF2A2, and RRM2 emerged as hub genes implicated in the pathogenesis. A line graph model provides diagnostic insights. Mendelian randomization analysis confirmed a causal link between CETN3 and GTF2A2 with OSA.ConclusionThrough WGCNA, this analysis uncovered significant genetic foundations of OSA, identifying 2,502 DEGs and 194 genes associated with the disorder. Among these, CETN3 and GTF2A2 were found to have causal relationships with OSA.https://www.frontiersin.org/articles/10.3389/fneur.2024.1442835/fullobstructive sleep apneadifferentially expressed genesWGCNAMendelian randomizationimmune infiltration
spellingShingle Nianjin Gong
Yu Tuo
Peijun Liu
Identification and Mendelian randomization validation of pathogenic gene biomarkers in obstructive sleep apnea
obstructive sleep apnea
differentially expressed genes
WGCNA
Mendelian randomization
immune infiltration
title Identification and Mendelian randomization validation of pathogenic gene biomarkers in obstructive sleep apnea
title_full Identification and Mendelian randomization validation of pathogenic gene biomarkers in obstructive sleep apnea
title_fullStr Identification and Mendelian randomization validation of pathogenic gene biomarkers in obstructive sleep apnea
title_full_unstemmed Identification and Mendelian randomization validation of pathogenic gene biomarkers in obstructive sleep apnea
title_short Identification and Mendelian randomization validation of pathogenic gene biomarkers in obstructive sleep apnea
title_sort identification and mendelian randomization validation of pathogenic gene biomarkers in obstructive sleep apnea
topic obstructive sleep apnea
differentially expressed genes
WGCNA
Mendelian randomization
immune infiltration
url https://www.frontiersin.org/articles/10.3389/fneur.2024.1442835/full
work_keys_str_mv AT nianjingong identificationandmendelianrandomizationvalidationofpathogenicgenebiomarkersinobstructivesleepapnea
AT yutuo identificationandmendelianrandomizationvalidationofpathogenicgenebiomarkersinobstructivesleepapnea
AT peijunliu identificationandmendelianrandomizationvalidationofpathogenicgenebiomarkersinobstructivesleepapnea